Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03963414
Title A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vinicius Ernani
Indications

lung small cell carcinoma

Therapies

Carboplatin + Durvalumab + Etoposide + Tremelimumab

Carboplatin + Durvalumab + Etoposide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.